Joint Formulary & PAD

Alimemazine tartrate - Urticaria

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
NFD1
SPC
Restrictions / Comments :
Important

Urticaria / pruritis

PAD Profile

ChemicalSubstance :
Alimemazine tartrate
Indication :
Urticaria
Group Name :
Keywords :
sedating antihistamines, trimeprazine, pruritis
Brand Names Include :
Valergan, Vallergan, Itzenal
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Committee Recommendations (2)

The PCN does not recommend Alimemazine for the treatment of Urticaria in children (over the age of 2 years) and adults

Alimemazine will be considered BLACK, for new patients, on the traffic light system

Patients whose treatment with Alimemazine was initiated by the NHS before this recommendation was made, must be reviewed by their prescriber within 6-12 months, but should be able to continue treatment until, the patient and their NHS consultant consider it appropriate to stop.

The PCN does not recommend alimemazine (trimeprazine) for the treatment of pruritis in eczema.

Alimemazine (trimeprazine) will be considered BLACK on the traffic light system for new patients

Patients whose treatment with alimemazine was initiated by the NHS before this recommendation was made, must be reviewed by their NHS consultant within 12 months but, should be able to continue treatment until the patient and their NHS consultant consider it appropriate to stop.

Other Indications

Below are listed other indications that Alimemazine tartrate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Urticaria.